Menu Search
Equities

Wanjia Group Holdings Ltd

401:HKG.HS

Wanjia Group Holdings Ltd

Actions
  • Price (HKD)0.072
  • Today's Change0.001 / 1.41%
  • Shares traded2.18m
  • 1 Year change-48.57%
  • Beta--
Data delayed at least 15 minutes, as of Jun 26 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Wanjia Group Holdings Ltd is an investment holding company principally engaged in the pharmaceutical wholesale and distribution business, and hemodialysis treatment and consultancy service business. The Company mainly operates its business through two segments. The Pharmaceutical Wholesale and Distribution Business segment mainly distributes pharmaceutical products for pharmaceutical retail chain stores, independent pharmacies and outpatient departments of community hospitals and healthcare service stations. The Hemodialysis Treatment and Consultancy Service Business segment mainly provides kidney care services and operates hemodialysis treatment centers.

  • Revenue in HKD (TTM)176.93m
  • Net income in HKD1.28m
  • Incorporated2012
  • Employees198.00
  • Location
    Wanjia Group Holdings LtdRoom 190219/F, No. 101 King's Road, North Point Hong KongHKG
  • Phone+852 23663375
  • Fax+852 27239025
  • Websitehttps://www.wanjia-gp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.